Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution
鲁索替尼联合辛伐他汀治疗 COVID-19 的随机 II 期临床试验:临床疗效和细胞因子演变
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2023.1156603
Garcia-Donas, Jesus; Martínez-Urbistondo, Diego; Velázquez Kennedy, Kyra; Villares, Paula; Barquin, Arántzazu; Dominguez, Andrea; Rodriguez-Moreno, Juan Francisco; Caro, Elena; Suarez Del Villar, Rafael; Nistal-Villan, Estanislao; Yagüe, Monica; Ortiz, Maria; Barba, Maria; Ruiz-Llorente, Sergio; Quiralte, Miguel; Zanin, Massimiliano; Rodríguez, Cristina; Navarro, Paloma; Berraondo, Pedro; Madurga, Rodrigo